GERN Geron Corp

4.18

0.10 (2.45%)

Pre Market

Last Updated: 12:07:49

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Geron Corp	NASDAQ:GERN	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.10	2.45%	4.18	4.16	4.20				2,290	12:07:49

Geron to Present at 2019 Cantor Global Healthcare Conference

26/09/2019 9:18pm

GlobeNewswire Inc.

Geron (NASDAQ:GERN)
Historical Stock Chart

From May 2019 to May 2024

Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at the 2019 Cantor Global Healthcare Conference in New York at 9:30 a.m. ET on Friday, October 4, 2019.

A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentation, an archived webcast will be available on the Company’s website for 30 days.

About Geron

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Suzanne MessereInvestor and Media Relationsinvestor@geron.commedia@geron.com

CG Capital877-889-1972